Metronidazole intravenous IV bulk supplier for pharma manufacturers

Metronidazole Intravenous Iv 500 mg/100 mL, 1 g/100 mL Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV)

Available Strengths: 500 mg/100 mL, 1 g/100 mL

Reference Brands: Flagyl(US), Metronidazol-Darnytsia (Ukraine)

Metronidazole IV inhibits bacterial and protozoal DNA synthesis by disrupting nucleic acid structures. It provides rapid, effective treatment for severe anaerobic infections, abscesses, and protozoal diseases. Benefits include quick bacterial eradication, good tissue penetration, and use in critical care when oral therapy isn’t feasible.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Metronidazole IV is approved in the EU and US for serious anaerobic bacterial and protozoal infections. In the EU, brands like Flagyl IV are regulated by EMA, supported by dossiers demonstrating safety, efficacy, and manufacturing standards. In the US, FDA approval relies on extensive clinical data; generic formulations are available. Both regions require detailed dossiers, including clinical trial data, manufacturing practices, and pharmacovigilance plans for approval and ongoing safety monitoring. For expert regulatory support, dossier preparation, and compliance, visit PharmaTradz. We facilitate seamless market access for metronidazole IV, ensuring adherence to European and US standards for safe, effective antimicrobial therapy in severe infections.

Metronidazole Intravenous Iv — third party manufacturing & bulk supply

Metronidazole Intravenous Iv 500 mg/100 mL, 1 g/100 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Metronidazole Intravenous Iv is supplied as Intravenous (IV) — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Metronidazole Intravenous Iv listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Metronidazole Intravenous Iv →

Back to Listing

Frequently Asked Questions

Metronidazole intravenous IV is used to treat serious infections caused by anaerobic bacteria and certain parasites. It is commonly prescribed for intra-abdominal infections, gynecological infections, skin and soft tissue infections, bone and joint infections, and septicemia caused by susceptible organisms. It is also used in the treatment of infections such as bacterial vaginosis, trichomoniasis, and amoebiasis when oral therapy is not suitable. The IV formulation is typically administered in hospital settings for moderate to severe infections.

Metronidazole intravenous IV contains the active pharmaceutical ingredient metronidazole, a synthetic nitroimidazole antimicrobial agent. It works by entering microbial cells and disrupting DNA synthesis, which leads to the death of susceptible bacteria and protozoa.

Metronidazole intravenous IV is marketed under several trade names worldwide including Flagyl IV, Metronidazole Injection, Metrogyl IV, and other generic metronidazole infusion brands depending on the manufacturer and region.

One of the well-known brands, Flagyl IV, was originally marketed by Pfizer. Today, metronidazole IV formulations are manufactured globally by many pharmaceutical companies including Sanofi, Fresenius Kabi, and Baxter International along with several generic manufacturers.

The generic name of Metronidazole intravenous IV is metronidazole.

Common brand names include Flagyl IV, Metrogyl IV, Metronidazole Injection, and other regional generic brands.

Metronidazole intravenous IV is manufactured in several countries including the United States, India, China, and multiple European countries by various pharmaceutical companies supplying hospital and clinical markets worldwide.